Loxo Oncology, Inc. — Form D
Loxo Oncology, Inc. of STAMFORD, CT, a company, filed a Form D exempt-offering notice with the SEC on 2014-05-12. The offering totals $23.9M, of which $23.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-05-12
- Form: D
- Accession: 0001581720-14-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $23.9M
- Amount sold: $23.9M
- Investors: 7
- Date of first sale: 2014-04-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-217142
Issuer
- Name: Loxo Oncology, Inc.
- CIK: 0001581720
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1 LANDMARK SQUARE, SUITE 1122, STAMFORD, CT, 06901
- Phone: 203-658-4749
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| James H Barrett | Director | Stamford, CT |
| Joshua H Bilenker | Director | Watertown, MA |
| David H Bonita | Director | Watertown, MA |
| Steven H Elms | Director | Watertown, MA |
| Keith H Flaherty | Director | Stamford, CT |
| Dov H Goldstein | Director | Stamford, CT |
| Avi H Naider | Director | Watertown, MA |
| Joshua H Bilenker | Executive Officer | Watertown, MA |
Other filings by this issuer (1)
More